ExecPay

Sekar Kathiresan

Overview202220212020

Overview

Sekar Kathiresan received an average of $5M in total compensation, including $523K in salary, at Verve Therapeutics from 2020 to 2022.

Source: SEC filings on April 28, 2023 and April 29, 2022.
Kathiresan's 2022 pay

Related executives

We found three more executives who work or worked at Verve Therapeutics.

Andrew Bellinger

Verve Therapeutics

Chief Scientific Officer

3

Andrew Ashe

Verve Therapeutics

Chief Operating Officer

1

Allison Dorval

Verve Therapeutics

Chief Financial Officer

1

News

You may also like

Verve Therapeutics